Lacosamide
Who holds supplier records for Lacosamide? 33 organisations hold a current record for Lacosamide: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 25 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (25), China (3), Italy (1) and Netherlands (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Lacosamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lacosamide
Reading the evidence
- 33 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
25 of the 30 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 17 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Lacosamide expires 5 Jun 2040. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (33)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Lacosamide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 39650, 26313 · latest filing Mar 2024
- BEIJING HOPE PHARMACEUTICAL CO LTDCEPActive DMF 40011, 33678 · latest filing May 2024
- INDOCO REMEDIES LTDIndiaCEP Company GMP cert on recordActive DMF 29476, 36788 · latest filing Mar 2022
- MSN PHARMACHEM PRIVATE LTDIndiaCEPActive DMF 26270, 34737 · latest filing Mar 2020
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 26349 · latest filing Sept 2012
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 26323 · latest filing Oct 2012
- CAMBREX PROFARMACO MILANO SRLItalyCEP Company GMP cert on recordActive DMF 29763 · latest filing Sept 2015
- CHIERON ACTIVE INGREDIENTS PRIVATE LTDIndiaCEPActive DMF 33552 · latest filing Feb 2019
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 40734 · latest filing Mar 2025
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 35724 · latest filing Mar 2021
- EMNAR PHARMA PRIVATE LTDIndiaCEPActive DMF 37446 · latest filing Aug 2022
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 26136 · latest filing Jun 2012
- HIKAL LTDIndiaCEP Company GMP cert on recordActive DMF 30345 · latest filing Feb 2016
- Intas Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 26520 · latest filing Oct 2012
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 29170 · latest filing Mar 2015
- LEE PHARMA LTDIndiaCEP Company GMP cert on recordActive DMF 41955 · latest filing May 2025
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 28797 · latest filing Nov 2014
- METROCHEM API PRIVATE LTDIndiaCEPActive DMF 38789 · latest filing Sept 2023
- Shandong Loncom Pharmaceutical Co.,ltd.ChinaCEPActive DMF 44128 · latest filing May 2026
- Viyash Scientific LtdIndiaCEP Company GMP cert on recordActive DMF 38978 · latest filing Feb 2024
- Wisdom Pharmaceutical Co., LtdChinaCEPActive DMF 34107 · latest filing Sept 2019
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 34784 · latest filing Apr 2020
- LUNA CHEMICALS CO LTDActive DMF 43254 · latest filing Dec 2025
- SIGNA SA DE CVActive DMF 26484 · latest filing Sept 2012
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 26250, 26174 · latest filing Oct 2012
- SYMPHONY PHARMA LIFESCIENCES PRIVATE LTDIndiaActive DMF 26594 · latest filing Dec 2012
- TAPI NL BVNetherlandsActive DMF 26381 · latest filing Sept 2012
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 32430 · latest filing Mar 2018
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 26472 · latest filing Oct 2012
- Aalidhra Pharmachem Private LimitedIndiaCEP
- IndiaCEP
- ChinaCEP Company GMP cert on record
- RAGHAVA LIFE SCIENCES PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (25)
Certificates of Suitability on the EDQM register for Lacosamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 29 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| WISDOM PHARMACEUTICAL CO., LTD. Haimen | CN | CEP 2020-283 - Rev 01 Lacosamide | Nov 2026 | — |
| MSN PHARMACHEM PRIVATE LIMITED Sangareddy | IN | CEP 2026-260 - Rev 00 Lacosamide, Route code-LS, crystalline form-I | Sept 2026 | — |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | CEP 2025-124 - Rev 00 Lacosamide | Aug 2026 | — |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2022-353 - Rev 02 Lacosamide | Jul 2026 | — |
| INDOCO REMEDIES LIMITED Mumbai | IN | CEP 2021-147 - Rev 03 Lacosamide, Process II | Jun 2026 | — |
| CAMBREX PROFARMACO MILANO S.R.L. Paullo | IT | CEP 2019-184 - Rev 01 Lacosamide | May 2026 | Inspected Sept 2025 Italy |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2021-163 - Rev 03 Lacosamide | May 2026 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2018-151 - Rev 02 Lacosamide | May 2026 | — |
| BEIJING HOPE PHARMACEUTICAL CO., LTD. Beijing | CN | CEP 2025-593 - Rev 00 Lacosamide, Shijiazhuang Site, process B | Apr 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2018-099 - Rev 04 Lacosamide, Form-I | Feb 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2019-049 - Rev 02 Lacosamide | Jan 2026 | — |
| CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad | IN | CEP 2019-048 - Rev 02 Lacosamide | Dec 2025 | — |
| VASUDHA PHARMA CHEM LIMITED Hyderabad | IN | CEP 2024-405 - Rev 00 Lacosamide | Nov 2025 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | CEP 2020-437 - Rev 03 Lacosamide | Oct 2025 | — |
| EMNAR PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2023-438 - Rev 00 Lacosamide | Oct 2025 | — |
| LEE PHARMA LIMITED Hyderabad | IN | CEP 2019-223 - Rev 01 Lacosamide | Oct 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2024-128 - Rev 02 Lacosamide, Process II | Jun 2025 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2018-276 - Rev 02 Lacosamide, Form-I | May 2025 | — |
| METROCHEM API PRIVATE LIMITED Hyderabad | IN | CEP 2023-365 - Rev 01 Lacosamide | Jan 2025 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2018-247 - Rev 02 Lacosamide, Form I, milled | Nov 2024 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2022-024 - Rev 01 Lacosamide | Sept 2024 | Inspected May 2026 Italy |
| AALIDHRA PHARMACHEM PRIVATE LIMITED Nandesari | IN | CEP 2023-039 - Rev 01 Lacosamide | Aug 2024 | — |
| HIKAL LIMITED Bangalore | IN | CEP 2020-107 - Rev 03 Lacosamide | May 2024 | Inspected Nov 2025 Switzerland |
| RAGHAVA LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2022-236 - Rev 00 Lacosamide | Nov 2023 | — |
| SHANDONG LONCOM PHARMACEUTICAL CO., LTD Qihe | CN | R0-CEP 2021-451 - Rev 01 Lacosamide | May 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Lacosamide are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- LUPIN MANUFACTURING SOLUTIONS LTDInactive DMF 27835 · filed Dec 2013
- CURIA MISSOURI INCInactive DMF 26382 · filed Sept 2012
- India · Inactive DMF 24599 · filed Feb 2011
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (81 listed products contain Lacosamide). The latest listed patent expires 5 Jun 2040. The latest listed exclusivity ended 28 Apr 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Lacosamide is an antiepileptic drug used primarily to treat partial-onset seizures. It works by selectively enhancing slow inactivation of voltage-gated sodium channels, thereby stabilizing hyperexcitable neuronal membranes.
Chemical identity
- IUPAC name
- (2R)-2-acetamido-N-benzyl-3-methoxypropanamide
- Canonical SMILES
- CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1
- InChIKey
- VPPJLAIAVCUEMN-GFCCVEGCSA-N
- Synonyms
- Vimpat API, (r)-lacosamide 1, add-243037, add243037, erlosamide, motpoly, spm-927, spm927, vimpat
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Physiologic effect
- Decreased Central Nervous System Disorganized Electrical Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Lacosamide?
33 organisations hold an active US FDA Type II Drug Master File or a CEP for Lacosamide: APITORIA PHARMA PRIVATE LTD (India), BEIJING HOPE PHARMACEUTICAL CO LTD, INDOCO REMEDIES LTD (India), MSN PHARMACHEM PRIVATE LTD (India), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), CAMBREX PROFARMACO MILANO SRL (Italy) and CHIERON ACTIVE INGREDIENTS PRIVATE LTD (India), and 25 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Lacosamide Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 39650, 26313), BEIJING HOPE PHARMACEUTICAL CO LTD (DMF 40011, 33678), INDOCO REMEDIES LTD (DMF 29476, 36788), MSN PHARMACHEM PRIVATE LTD (DMF 26270, 34737), Alembic Pharmaceuticals Limited (DMF 26349), ALIVUS LIFE SCIENCES LTD (DMF 26323), CAMBREX PROFARMACO MILANO SRL (DMF 29763) and CHIERON ACTIVE INGREDIENTS PRIVATE LTD (DMF 33552) and 21 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Lacosamide records mean?
3 organisations have only inactive Type II DMFs for Lacosamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Lacosamide have a European Certificate of Suitability?
Yes. 25 organisations hold a valid CEP for Lacosamide on the EDQM register, including WISDOM PHARMACEUTICAL CO., LTD. Haimen (CN), MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN), CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), INDOCO REMEDIES LIMITED Mumbai (IN) and CAMBREX PROFARMACO MILANO S.R.L. Paullo (IT) and 19 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Lacosamide?
Yes. The latest patent listed for an approved US product containing Lacosamide expires 5 Jun 2040, across 81 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Lacosamide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Lacosamide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.